Kaneka Logo
Health Care Providers PhotoFor Health Care Professionals

Introduction

The LIPOSORBER® System is indicated for use in performing low density lipoprotein cholesterol (LDL-C) apheresis to acutely remove LDL-C from the plasma of the following high risk patient populations for whom diet has been ineffective and maximum drug therapy has either been ineffective or not tolerated:

  • Patients with LDL-C >300 mg/dl
  • Patients with LDL-C >200 mg/dl and documented coronary heart disease (CHD).

KANEKA MA-03 PA2 Apheresis Machine Operation

 

© Copyright Kaneka Pharma America, LLC . All rights reserved.

The information on this site is intended for U.S. residents only.